Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-10188 |
Trade Name | |
Synonyms | BGB 10188|BGB10188 |
Drug Descriptions |
BGB-10188 selectively inhibits PI3K-delta, potentially resulting in anti-tumor activity (Cancer Res 2020;80(16 Suppl):Abstract nr 664). |
DrugClasses | PIK3CD inhibitor 27 |
CAS Registry Number | NA |
NCIT ID | C175971 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-10188 | BGB-10188 | 0 | 1 |
BGB-10188 + Tislelizumab | BGB-10188 Tislelizumab | 0 | 1 |
BGB-10188 + Zanubrutinib | BGB-10188 Zanubrutinib | 0 | 1 |